Denopsy 14 — Teriflunomide 14 mg (30 Tablets)
Denopsy 14 (Teriflunomide) is a modern immunomodulatory drug designed for the disease-modifying treatment of multiple sclerosis. Teriflunomide is a selective inhibitor of the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH), which plays a key role in pyrimidine synthesis. Through this mechanism, the drug selectively limits the proliferation of hyperactive lymphocytes (T and B cells) responsible for inflammation and nerve fiber damage in multiple sclerosis.
Manufacturer: Natco Pharma, India. Denopsy 14 effectively reduces the frequency of exacerbations (relapses) and slows the progression of physical disability. The drug features a convenient dosing form and a good safety profile, making it a preferred choice for long-term maintenance therapy.
Key Features:
- ✅ Disease Control: Significant reduction in the risk of developing new brain lesions visible on MRI.
- ✅ Convenient Regimen: Oral administration once a day eliminates the need for frequent injections, improving treatment compliance.
- ✅ Selectivity: The drug targets active lymphocytes while preserving the overall protective function of the immune system.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 21.04.2026
What Customers Say
No reviews yet
Your review can be the first!